Company Filing History:
2 out of 1,975 
1 out of 179 
1 out of 119 
Years Active: 2011
Title: Kelly Sue Warmington: Innovator in Sclerostin Research
Introduction
Kelly Sue Warmington is a prominent inventor based in Newbury Park, CA (US). She has made significant contributions to the field of biotechnology, particularly in the study of sclerostin protein and its implications in various medical applications. With a total of 2 patents, her work has garnered attention in the scientific community.
Latest Patents
Warmington's latest patents include innovative compositions and methods relating to epitopes of sclerostin protein. One of her notable patents focuses on sclerostin binding agents, such as antibodies capable of binding to sclerostin. This research has the potential to advance therapeutic strategies in treating conditions related to bone metabolism.
Career Highlights
Throughout her career, Kelly Sue Warmington has worked with leading companies in the biotechnology sector, including Amgen Inc. and UCB Pharma, S.A. Her experience in these organizations has allowed her to collaborate with some of the brightest minds in the industry, further enhancing her expertise and contributions to the field.
Collaborations
Some of her notable coworkers include Martyn Kim Robinson and Alistair James Henry. Their collaborative efforts have played a crucial role in advancing research related to sclerostin and its applications.
Conclusion
Kelly Sue Warmington's innovative work in the field of sclerostin research highlights her significant contributions to biotechnology. Her patents and collaborations reflect her dedication to advancing medical science and improving therapeutic options.